lutein has been researched along with Diabetic Retinopathy in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Z; Lam, WC; Lee, JC; Leung, HH; Li, LH; Lo, ACY | 1 |
| Chan, KLS; Goit, RK; Lo, ACY; Ng, TC; Tam, KC; Wang, W | 1 |
| Davey, PG; Gierhart, DL; Lem, DW | 1 |
| Han, Y; Li, QS; Ma, L; Sun, SL; Wang, LY; Wang, ZL; Wu, CR; Zhang, PC | 1 |
| Luan, HQ; Qi, YX; Ren, YB; Su, XJ; Sun, Q | 1 |
| Alam, M; Bartsch, DU; Camacho, N; Espina, M; Freeman, WR; Mendoza, N; You, QS | 1 |
| Brady, WE; Donahue, RP; Klein, BE; Klein, R; Mares, JA; Meyers, KJ; Millen, AE; Ochs-Balcom, HM; Sahli, MW | 1 |
| Au Eong, KG; Goenadi, CJ; Lun, K; Neelam, K; Yip, CC | 1 |
| Brazionis, L; Itsiopoulos, C; O'Dea, K; Rowley, K | 1 |
| Almansa, I; Arnal, E; Barcia, JM; Bosch-Morell, F; Diaz-Llopis, M; Miranda, M; Muriach, M; Romero, FJ | 1 |
| Alvarez-Nölting, R; Araiz, J; Arnal, E; Bosch-Morell, F; Cervera, E; Díaz-Llopis, M; Johnsen-Soriano, S; Miranda, M; Romero, FJ | 1 |
| Ishida, S; Kobayashi, S; Kubota, S; Kurihara, T; Noda, K; Ozawa, Y; Sasaki, M; Tsubota, K; Yuki, K | 1 |
| Dorairaj, S; Farah, ME; Lima, VC; Maia, M; Prata, TS; Rosen, RB; Sallum, J | 1 |
| Chen, F; Huangfu, J; Jiang, Y; Liu, J; Sun, Z; Wang, M; Zeng, X | 1 |
| Charbel Issa, P; Chong, NV; Hickey, D; Kiire, CA; Mahmud, I; Waldstein, SM | 1 |
| Araiz, J; Bosch-Morell, F; Johnsen, S; Miranda, M; Muriach, M; Romá, J; Romero, FJ | 1 |
| Seiler, T; Wollensak, J | 2 |
3 review(s) available for lutein and Diabetic Retinopathy
| Article | Year |
|---|---|
Lutein Supplementation for Eye Diseases.
Topics: Animals; Biological Availability; Cataract; Diabetic Retinopathy; Diet; Dietary Supplements; Eye Diseases; Humans; Lutein; Macula Lutea; Macular Degeneration; Myopia; Plants, Edible; Retinopathy of Prematurity | 2020 |
A Systematic Review of Carotenoids in the Management of Diabetic Retinopathy.
Topics: Animals; Antioxidants; Carotenoids; Diabetic Retinopathy; Dietary Supplements; Humans; Lutein; Macular Pigment; Zeaxanthins | 2021 |
Putative protective role of lutein and zeaxanthin in diabetic retinopathy.
Topics: Animals; Antioxidants; Diabetic Retinopathy; Dietary Supplements; Disease Models, Animal; Humans; Lutein; Macular Degeneration; Neuroprotective Agents; Reactive Oxygen Species; Zeaxanthins | 2017 |
1 trial(s) available for lutein and Diabetic Retinopathy
| Article | Year |
|---|---|
Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy.
Topics: Aged; Contrast Sensitivity; Diabetic Retinopathy; Dietary Supplements; Double-Blind Method; Female; Humans; Lutein; Male; Middle Aged; Placebos; Visual Acuity | 2017 |
14 other study(ies) available for lutein and Diabetic Retinopathy
| Article | Year |
|---|---|
Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Inflammation; Lutein; Male; Mice; Mice, Inbred C57BL; Retina; Vascular Endothelial Growth Factor A | 2020 |
Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study.
Topics: Antioxidants; Contrast Sensitivity; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dietary Supplements; Drug Monitoring; Female; Humans; Lutein; Male; Middle Aged; Oxidative Stress; Retrospective Studies; Treatment Outcome; Visual Acuity | 2019 |
REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.
Topics: Adult; Aged; Aged, 80 and over; Densitometry; Diabetic Retinopathy; Female; Humans; Lutein; Macular Degeneration; Macular Edema; Macular Pigment; Male; Middle Aged; Optical Imaging; Reproducibility of Results; Zeaxanthins | 2016 |
Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC).
Topics: Aged; Atherosclerosis; Black or African American; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diet; Feeding Behavior; Glycated Hemoglobin; Humans; Lutein; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Surveys and Questionnaires; White People | 2016 |
Plasma carotenoids and diabetic retinopathy.
Topics: Adult; Aged; Antioxidants; beta Carotene; Biomarkers; Blood Glucose; Carotenoids; Chi-Square Distribution; Cross-Sectional Studies; Cryptoxanthins; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Lutein; Lycopene; Male; Middle Aged; Risk; Xanthophylls; Zeaxanthins | 2009 |
Lutein prevents cataract development and progression in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar | 2009 |
Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Biomarkers; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Docosahexaenoic Acids; Drug Therapy, Combination; Electroretinography; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Glutathione; Glutathione Peroxidase; In Situ Nick-End Labeling; Insulin; Lutein; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Retina; Tyrosine | 2009 |
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes.
Topics: Analysis of Variance; Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dietary Supplements; Extracellular Signal-Regulated MAP Kinases; Lutein; Mice; Nerve Degeneration; Oxidative Stress; Reactive Oxygen Species; Retina; Synaptophysin | 2010 |
Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study.
Topics: Densitometry; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glycated Hemoglobin; Humans; Image Enhancement; Lipids; Lutein; Male; Middle Aged; Ophthalmoscopy; Prospective Studies; Retina; Retinal Pigments; Xanthophylls; Zeaxanthins | 2010 |
Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.
Topics: Cell Line; Cell Proliferation; Chlorella; Diabetic Retinopathy; Eicosapentaenoic Acid; Glycation End Products, Advanced; Humans; Lutein; Matrix Metalloproteinase 2; Microalgae; Plant Extracts; RNA, Messenger; Up-Regulation; Vascular Endothelial Growth Factor A; Xanthophylls | 2011 |
Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema.
Topics: Cross-Sectional Studies; Densitometry; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Lutein; Macular Edema; Male; Middle Aged; Observer Variation; Ophthalmoscopy; Retinal Pigments; Retrospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence; Xanthophylls; Zeaxanthins | 2012 |
[Oxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidants].
Topics: Animals; Antioxidants; Azoles; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Isoindoles; Lutein; Male; Mice; Organoselenium Compounds; Oxidative Stress | 2004 |
[Berlin dye laser].
Topics: Diabetic Retinopathy; Hemoglobins; Humans; Laser Therapy; Lasers; Lutein; Melanins; Retinal Diseases | 1984 |
[The Berlin dye laser].
Topics: Diabetic Retinopathy; Hemoglobins; Humans; Laser Therapy; Lutein; Melanins | 1985 |